NHS England and UK medication watchdogs announced the pill anastrozole will now be offered as a cancer preventative thanks to a new approvals process that repurposes old drugs for new uses.

The news that the U.K. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster. But the fact that ...

One such drug option is anastrozole. The hormone therapy has been used for years to treat breast cancer, and has now been licensed to prevent the disease from developing in the first place.

Nearly 300,000 women in England will be offered a preventative pill to help them avoid breast cancer. The drug, anastrozole, has been available for years as a breast cancer treatment, and had ...

Anastrozole, a daily pill to prevent breast cancer, will now be available to thousands of more women in the UK after being cleared for wider use. The drug has been used to treat hormone-driven ...

A new study published in The Lancet Oncology discusses the efficacy of anastrozole, a molecule used to prevent breast cancer in postmenopausal women with a high risk of breast cancer. Study ...

This medication is a non-steroidal inhibitor used with other treatments, such as surgery or radiation, to treat early breast cancer in women who have experienced menopause.

London: Anastrozole, a daily pill to prevent breast cancer, will now be available to thousands of more women in the UK after being cleared for wider use. The drug has been used to treat hormone ...

Anastrozole, used for many years to treat the disease, has now been licensed as a preventative option. Recent trials show the drug can reduce the incidence of breast cancer by almost 50% in post ...